Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
23
NMPA:23
Drug Approvals
Tolvaptan Orally Disintegrating Tablets
- Product Name
- 托伐普坦口崩片
- Approval Number
- 国药准字H20254195
- Approval Date
- May 20, 2025
NMPA
Tolvaptan Orally Disintegrating Tablets
- Product Name
- 托伐普坦口崩片
- Approval Number
- 国药准字H20254194
- Approval Date
- May 20, 2025
NMPA
Pheniramine Maleate Naphazoline Hydrochloride Eye Drops
- Product Name
- 马来酸非尼拉敏盐酸萘甲唑啉滴眼液
- Approval Number
- 国药准字H20253223
- Approval Date
- Jan 14, 2025
NMPA
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution
- Product Name
- 硫酸镁钠钾口服用浓溶液
- Approval Number
- 国药准字H20249371
- Approval Date
- Nov 15, 2024
NMPA
Amisulpride Oral Solution
- Product Name
- 氨磺必利口服溶液
- Approval Number
- 国药准字H20244722
- Approval Date
- Aug 27, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20233863
- Approval Date
- Jun 30, 2023
NMPA
Pregabalin Oral Solution
- Product Name
- 普瑞巴林口服溶液
- Approval Number
- 国药准字H20233752
- Approval Date
- Jun 21, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found